Mucosal Melanoma
📧 Sign up to get email alerts when something new happens for Mucosal Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases [Phase 1]
Phase 1 trial evaluating stereotactic radiosurgery, NovoTTF-200M, and immune checkpoint inhibitors for melanoma brain metastases was termina…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery [Phase 2]
A Phase 2 clinical trial evaluating nivolumab alone or in combination with cabozantinib to prevent recurrence of mucosal melanoma after surg…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma [Phase 2]
Clinical trial update on using SHR-1701 plus famitinib as neoadjuvant therapy with response-guided adjuvant treatment for resectable mucosal…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma [Phase 1]
Phase 1 trial update reports proof of concept for TBio-4101 in combination with lymphodepleting chemotherapy and IL-2 for relapsed/refractor…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease [Phase 1]
Phase 1 study evaluating intravenous and intrathecal nivolumab for leptomeningeal disease in melanoma and non-small cell lung cancer patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma
The study evaluates the prognostic value of [18F]FDG PET/CT imaging in mucosal melanoma.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
An observational study examining off-label insurance coverage for patients with select cutaneous cancers, sponsored by Ohio State University…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma [Phase 1]
A Phase 1-1b clinical trial is evaluating the safety, preliminary efficacy, and dosimetry of study drug A9-3408 in patients with metastatic …
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases [Phase 1]
This phase 1 study assessed pembrolizumab in combination with stereotactic radiosurgery for patients with brain metastases from melanoma or …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) [Phase 2]
A Phase 2 neoadjuvant trial (Neo IRENIE) evaluating a triple combination of ipilimumab, relatlimab, and nivolumab in resectable cutaneous an…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Axitinib and Nivolumab for the Treatment of Mucosal Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of axitinib and nivolumab for mucosal melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Neo-adjuvant Immunotherapy in Patients With Localized Melanoma [Phase 2]
Phase 2 clinical trial update on neo-adjuvant immunotherapy for localized melanoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery [Phase 2]
Phase 2 trial evaluating sintilimab in combination with chemotherapy as adjuvant treatment for mucosal melanoma after surgery; recruitment i…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma [Phase 1]
Phase 1 trial of the modified virus VSV-IFNbetaTYRP1 in stage III-IV melanoma was terminated.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma [Phase 2]
Phase 2 clinical trial evaluating a combination including iparomlimab and tuvoraleimab with bevacizumab, nab-paclitaxel, and carboplatin as …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma [Phase 2]
A Phase 2 single-arm neoadjuvant trial evaluating Paclitaxel Polymersomes with Carboplatin and Adebelimab in patients with resectable mucosa…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma [Phase 1, Phase 2]
Clinical trial update describes a Phase 1/2 study of oral decitabine/cedazuridine (DEC-C) in combination with nivolumab for patients with mu…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma [Phase 2]
A Phase 2 trial named Clear Me aims to detect and clear molecular residual disease in high-risk melanoma and is currently recruiting, includ…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of Carilizumab, Apatinib, and radiotherapy for advanced mucosal melanoma, which is cu…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial [Phase 2]
Phase 2 trial evaluating time-of-day specified immunotherapy for advanced melanoma; currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases [Phase 2]
Phase 2 study compares encorafenib + binimetinib + nivolumab versus ipilimumab + nivolumab in BRAF-V600 mutation melanoma with brain metasta…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of APG-115 alone or with pembrolizumab in metastatic melanoma and other advanced solid tumors; the trial is currently active…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 [Phase 2]
The ARTISTRY-6 Phase 2 trial evaluating nemvaleukin alfa as monotherapy and in combination with pembrolizumab in patients with advanced cuta…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy [Phase 2]
Phase 2 study evaluating IBI363 monotherapy versus pembrolizumab for unresectable locally advanced or metastatic mucosal or acral melanoma i…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor [Phase 2]
A Phase 2 trial evaluating the combination of Vactosertib and Pembrolizumab in acral and mucosal melanoma patients who progressed on prior i…